
Opinion|Videos|July 17, 2024
Vitiligo Treatment Strategies: Addressing Skin of Color Considerations, Long-Term Regimentation, and Disease Management
Author(s)Andrew F. Alexis, MD, MPH
Andrew Alexis, MD, MPH, presents the case of a 60-year-old man with a 5-year history of vitiligo who received topical ruxolitinib 1.5% cream and achieved gradual repigmentation over a six-month period.
Advertisement
Episodes in this series
Video content above is prompted by the following questions:
- What is your impression of this case?
- What challenges does this case present with, if any?
- How do you decide when to consider transitioning to a different treatment vs continuing the current course?
- How would you approach the next steps of treatment for this patient?
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Transformative Advances This Year and Beyond
2
FDA Proposes Expansion of US Sunscreen Ingredient Standards with Bemotrizinol
3
Phase 3b Study Confirms Ligelizumab’s Consistent CSU Control
4
"PDE4 Inhibitor-Responsive Dermatoses": A Modern Framework for Managing Inflammatory Skin Conditions
5




















